PW Medtech Group Limited (1358.HK)
HKSE · HKD · Healthcare · Medical Instruments & Supplies
HK$0.89 (-0.56%) as of
Key statistics
- Market cap
- 1.26B
- P/E (TTM)
- 29.67
- EPS (TTM)
- 0.030
- Dividend yield
- 2.46%
- 52-week range
- 0.855 – 1.520
- Beta
- 0.69
- Revenue (TTM)
- 803.19M
- Profit margin
- 5.36%
- Volume
- 129.00k
About PW Medtech Group Limited
PW Medtech Group Limited, an investment holding company, operates as a medical device company in China, India, the Americas, Africa, the rest of Asia, and internationally. It operates in three segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business. The company offers advanced infusion sets, such as non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and insulin needles and pens; hemodialysis and blood purification medical devices; and high-flux hemodialyzers, low-flux hemodialyzers, hemodiafilters, hemoperfutors, and dialysis machines. It also provides animal-derived regenerative medical biomaterials and human tissue repair alternative products. The company was formerly known as Pyholding Limited and changed its name to PW Medtech Group Limited in June 2013. PW Medtech Group Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Headquarters
- Beijing, China
- Employees
- 1,433
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.